We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOON:SIXSonova Holding AG Analysis

Data as of 2026-03-13 - not real-time

CHF 194.10

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Sonova Holding AG (SOON.SW) is trading at CHF 194.1, which sits below its 20‑day (CHF 196.3), 50‑day (CHF 205.5) and 200‑day (CHF 220.6) simple moving averages, signaling a bearish price trend. The RSI of 43.7 suggests the stock is not yet oversold, while the MACD line has just crossed above its signal line, producing a modest bullish histogram of 0.11 and hinting at a possible short‑term bounce. Volume is increasing and the 30‑day volatility is high at 31.3%, but the computed beta of 0.35 indicates low systematic risk relative to the market. Support sits at CHF 187.35 and resistance at CHF 204.90, giving the price a narrow trading range with limited upside in the near term.
Fundamentally, Sonova delivers strong profitability with a gross margin of 71.8%, operating margin of 14.3% and ROE of 22.2%, while revenue is flat year‑over‑year (‑1%). The forward P/E of 17.7 is well below the industry average of 26.2, and the dividend yield of 2.27% is supported by a 50.5% payout ratio and solid cash flow. Analysts average a target price of CHF 229, implying roughly 18% upside, yet the DCF fair value of CHF 152.2 suggests the current market price may be overvalued. The company’s moderate debt‑to‑equity (60.5%) and healthy free cash flow further underpin its financial stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major SMAs indicating bearish bias
  • Bullish MACD crossover and rising volume
  • Proximity to support level at CHF 187.35

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E of 17.7 versus industry average of 26.2
  • Analyst target price around CHF 229 (+18% upside)
  • Stable dividend yield of 2.27% with 50% payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong ROE (22%) and cash flow generation
  • Diversified global footprint reducing geographic concentration
  • Current price above DCF fair value, limiting upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth-1.00%
Profit Margin13.53%
P/E Ratio22.3
ROE22.17%
ROA8.29%
Debt/Equity60.51
P/B Ratio4.8
Op. Cash FlowCHF819.8M
Free Cash FlowCHF740.1M
Industry P/E26.2

Technical Analysis

TrendBearish
RSI43.7
SupportCHF 187.35
ResistanceCHF 204.90
MA 20CHF 196.29
MA 50CHF 205.54
MA 200CHF 220.57
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair ValueCHF 152.19
Target PriceCHF 228.06
Upside/Downside17.49%
GradeFair
TypeBlend
Dividend Yield2.27%

Risk Assessment

Beta0.35
Volatility31.30%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.